Platforms & Performance

Gene therapy

Celerion’s rapidly expanding gene therapy focus supports our clients’ bioanalytical needs for drug development by utilizing our international laboratories and top-fight scientists.

The Evolving Role of Gene Therapy in Drug Development

Gene therapy medicinal products (GTMPs) generally consist of a vector or delivery formulation/ system with an expressed therapeutic sequence including a genetic construct expressing therapeutic sequence or protein used to therapeutically target a genetic sequence for regulation, repair, addition or deletion.

Gene Therapy Product Support for

siRNA, RNA and DNA and Oligos
Encapsulated and naked plasmids and mRNAs
Viral vectors (adenovirus vectors (AdVs), adeno-associated virus vectors (AAVs), baculoviral vectors (BVs) and lentivirus vectors (LV))

Bioanalytical Strategy for Gene Therapy Product Development

Gene Therapy

Biomarkers for Immuno-Oncology

View White Paper